Species- and cell type-specific requirements for cellular transformation

Cancer Cell

Volumn 6, Issue 2, 2004, Pages 171-183

  Rangarajan, Annapoorni ^a   Hong, Sue J ^b   Gifford, Annie ^a   Weinberg, Robert A ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN P53; PROTEIN PP2A; PROTEIN PRB; RAF PROTEIN; TELOMERASE; UNCLASSIFIED DRUG; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PHOSPHOPROTEIN PHOSPHATASE; RETINOBLASTOMA PROTEIN;

ARTICLE; BREAST EPITHELIUM; CARCINOGENESIS; CELL IMMORTALIZATION; CELL TRANSFORMATION; CELL TYPE; CONTROLLED STUDY; EMBRYO CELL; ENZYME ACTIVATION; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; KIDNEY CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; CELL AGING; CELL CULTURE; CYTOLOGY; METABOLISM; MOUSE; NUDE MOUSE; PHYSIOLOGY; SIMIAN VIRUS 40; SPECIES DIFFERENCE;

MURINAE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL AGING; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; ENZYME ACTIVATION; FIBROBLASTS; HUMANS; MICE; MICE, NUDE; PHOSPHOPROTEIN PHOSPHATASE; PROTO-ONCOGENE PROTEINS C-RAF; RAL GUANINE NUCLEOTIDE EXCHANGE FACTOR; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; SPECIES SPECIFICITY; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 4344646902     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.07.009     Document Type: Article

References (40)

1. Bos J.L. Ras oncogenes in human cancer. A review Cancer Res. 49:1989;4682-4689
2. Campbell S.L., Khosravi-Far R., Rossman K.L., Clark G.J., Der C.J. Increasing complexity of Ras signaling. Oncogene. 17:1998;1395-1413
3. Chen W., Possemato R., Campbell K.T., Plattner C.A., Pallas D.C., Hahn W.C. Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell. 5:2004;127-136
4. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer. 3:2003;11-22
5. Drayton S., Rowe J., Jones R., Vatcheva R., Cuthbert-Heavens D., Marshall J., Fried M., Peters G. Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. Cancer Cell. 4:2003;301-310
6. Elenbaas B., Spirio L., Koerner F., Fleming M.D., Zimonjic D.B., Donaher J.L., Popescu N.C., Hahn W.C., Weinberg R.A. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15:2001;50-65
7. Hahn W.C., Weinberg R.A. Modelling the molecular circuitry of cancer. Nat. Rev. Cancer. 2:2002;331-341. a
8. Hahn W.C., Weinberg R.A. Rules for making human tumor cells. N. Engl. J. Med. 347:2002;1593-1603. b
9. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., Weinberg R.A. Creation of human tumour cells with defined genetic elements. Nature. 400:1999;464-468
10. Hahn W.C., Dessain S.K., Brooks M.W., King J.E., Elenbaas B., Sabatini D.M., DeCaprio J.A., Weinberg R.A. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell. Biol. 22:2002;2111-2123
11. Hamad N.M., Elconin J.H., Karnoub A.E., Bai W., Rich J.N., Abraham R.T., Der C.J., Counter C.M. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 16:2002;2045-2057
12. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70
13. Harvey M., Sands A.T., Weiss R.S., Hegi M.E., Wiseman R.W., Pantazis P., Giovanella B.C., Tainsky M.A., Bradley A., Donehower L.A. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene. 8:1993;2457-2467
14. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25:1961;585-621
15. Huot T.J., Rowe J., Harland M., Drayton S., Brookes S., Gooptu C., Purkis P., Fried M., Bataille V., Hara E., et al. Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts. Mol. Cell. Biol. 22:2002;8135-8143
16. Janssens V., Goris J. Protein phosphatase 2A. A highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling Biochem. J. 353:2001;417-439
17. Kamijo T., Zindy F., Roussel M.F., Quelle D.E., Downing J.R., Ashmun R.A., Grosveld G., Sherr C.J. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell. 91:1997;649-659
18. Krimpenfort P., Quon K.C., Mooi W.J., Loonstra A., Berns A. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature. 413:2001;83-86
19. Newbold R.F., Overell R.W., Connell J.R. Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens. Nature. 299:1982;633-635
20. Oldham S.M., Clark G.J., Gangarosa L.M., Coffey R.J. Jr., Der C.J. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Proc. Natl. Acad. Sci. USA. 93:1996;6924-6928
21. Rangarajan A., Weinberg R.A. Opinion. Comparative biology of mouse versus human cells: Modelling human cancer in mice Nat. Rev. Cancer. 3:2003;952-959
22. Rodriguez-Viciana P., Warne P.H., Khwaja A., Marte B.M., Pappin D., Das P., Waterfield M.D., Ridley A., Downward J. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell. 89:1997;457-467
23. Sage J., Mulligan G.J., Attardi L.D., Miller A., Chen S., Williams B., Theodorou E., Jacks T. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14:2000;3037-3050
24. Sager R. Senescence as a mode of tumor suppression. Environ. Health Perspect. 93:1991;59-62
25. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602
26. Sharpless N.E., Bardeesy N., Lee K.H., Carrasco D., Castrillon D.H., Aguirre A.J., Wu E.A., Horner J.W., DePinho R.A. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature. 413:2001;86-91
27. Shay J.W. Telomerase in human development and cancer. J. Cell. Physiol. 173:1997;266-270
28. Sherr C.J. The INK4a/ARF network in tumour suppression. Nat. Rev. Mol. Cell Biol. 2:2001;731-737
29. Sherr C.J., McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2:2002;103-112
30. Shields J.M., Pruitt K., McFall A., Shaub A., Der C.J. Understanding Ras. 'It ain't over 'til it's over' Trends Cell Biol. 10:2000;147-154
31. Tevethia M.J., Pipas J.M., Kierstead T., Cole C. Requirements for immortalization of primary mouse embryo fibroblasts probed with mutants bearing deletions in the 3′ end of SV40 gene A. Virology. 162:1988;76-89
32. Todaro G.J., Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17:1963;299-313
33. Urano T., Emkey R., Feig L.A. Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J. 15:1996;810-816
34. Vaziri H., Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8:1998;279-282
35. Voorhoeve P.M., Agami R. The tumor-suppressive functions of the human INK4A locus. Cancer Cell. 4:2003;311-319
36. Wei S., Sedivy J.M. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res. 59:1999;1539-1543
37. Wei W., Hemmer R.M., Sedivy J.M. Role of p14(ARF) in replicative and induced senescence of human fibroblasts. Mol. Cell. Biol. 21:2001;6748-6757
38. Wolthuis R.M., de Ruiter N.D., Cool R.H., Bos J.L. Stimulation of gene induction and cell growth by the Ras effector Rlf. EMBO J. 16:1997;6748-6761
39. Yan J., Roy S., Apolloni A., Lane A., Hancock J.F. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J. Biol. Chem. 273:1998;24052-24056
40. Yeh E., Cunningham M., Arnold H., Chasse D., Monteith T., Ivaldi G., Hahn W.C., Stukenberg P.T., Shenolikar S., Uchida T., et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 6:2004;308-318